Synergy on Surfaces : Anti-Biofouling Interfaces Using Surface-Attached Antimicrobial Peptides PGLa and Magainin-2

The synergistic effect of antimicrobial compounds is an important phenomenon that can increase the potency of treatment and might be useful against the formation of biofilms on surfaces. A strong inhibition of microbial viability on surfaces can potentially delay the development of biofilms on treat...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 34(2018), 37 vom: 18. Sept., Seite 11147-11155
1. Verfasser: Shtreimer Kandiyote, Nitzan (VerfasserIn)
Weitere Verfasser: Mohanraj, Gunasekaran, Mao, Canwei, Kasher, Roni, Arnusch, Christopher J
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Anti-Bacterial Agents Antimicrobial Cationic Peptides Magainins Membranes, Artificial Xenopus Proteins peptide-Gly-Leu-amide 102068-15-5 magainin 2 peptide, Xenopus 108433-95-0
LEADER 01000naa a22002652 4500
001 NLM287607216
003 DE-627
005 20231225054407.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.8b01617  |2 doi 
028 5 2 |a pubmed24n0958.xml 
035 |a (DE-627)NLM287607216 
035 |a (NLM)30122046 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Shtreimer Kandiyote, Nitzan  |e verfasserin  |4 aut 
245 1 0 |a Synergy on Surfaces  |b Anti-Biofouling Interfaces Using Surface-Attached Antimicrobial Peptides PGLa and Magainin-2 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 27.12.2018 
500 |a Date Revised 27.12.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a The synergistic effect of antimicrobial compounds is an important phenomenon that can increase the potency of treatment and might be useful against the formation of biofilms on surfaces. A strong inhibition of microbial viability on surfaces can potentially delay the development of biofilms on treated surfaces, thereby enhancing the performance of water-purification technologies and medical devices, for example, to prevent hospital-acquired infections. However, the synergistic effects of surface-immobilized antimicrobial peptides (AMPs) have not yet been reported. Here, we demonstrate the synergistic antimicrobial effects of the AMPs PGLa and magainin-2 on modified reverse-osmosis (RO) membranes. These AMPs are known to act synergistically in the free state, but their antimicrobial synergistic effects have not yet been reported in a surface-immobilized state. The AMPs were functionalized with alkyne linkers and covalently attached to RO membranes modified with azides, using a click chemistry reaction. The resulting RO membranes showed reduced contact angles, indicating increased wettability. X-ray photoelectron spectroscopy confirmed the presence of the two peptides on the membranes via changes in the amounts of carbon, oxygen, and sulfur, which led to an increased S/C ratio, probably because of the sulfur present in the methionine residue of the peptides. The synergistic activity was measured with the free peptides in solution and covalently bound on RO membrane surfaces by observing increased leakage of 5(6)-carboxyfluorescein from large unilamellar vesicles. The synergistic antimicrobial activity against Pseudomonas aeruginosa was observed using surface-activity assays, where the AMP-modified RO membranes showed an effective inhibition of P. aeruginosa biofilm growth, as compared with unmodified membranes. An enhanced activity of antimicrobials on surfaces might lead to potent antimicrobial surfaces, which could result in more fouling-resistant water-treatment membranes 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Anti-Bacterial Agents  |2 NLM 
650 7 |a Antimicrobial Cationic Peptides  |2 NLM 
650 7 |a Magainins  |2 NLM 
650 7 |a Membranes, Artificial  |2 NLM 
650 7 |a Xenopus Proteins  |2 NLM 
650 7 |a peptide-Gly-Leu-amide  |2 NLM 
650 7 |a 102068-15-5  |2 NLM 
650 7 |a magainin 2 peptide, Xenopus  |2 NLM 
650 7 |a 108433-95-0  |2 NLM 
700 1 |a Mohanraj, Gunasekaran  |e verfasserin  |4 aut 
700 1 |a Mao, Canwei  |e verfasserin  |4 aut 
700 1 |a Kasher, Roni  |e verfasserin  |4 aut 
700 1 |a Arnusch, Christopher J  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1992  |g 34(2018), 37 vom: 18. Sept., Seite 11147-11155  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:34  |g year:2018  |g number:37  |g day:18  |g month:09  |g pages:11147-11155 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.8b01617  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 34  |j 2018  |e 37  |b 18  |c 09  |h 11147-11155